163 related articles for article (PubMed ID: 23062933)
21. Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer.
Nakata K; Sakata K; Someya M; Miura K; Hayashi J; Hori M; Takagi M; Himi T; Kondo A; Hareyama M
J Radiat Res; 2013 Jul; 54(4):679-83. PubMed ID: 23292146
[TBL] [Abstract][Full Text] [Related]
22. Outpatient oral chemotherapy with S-1 for unresectable or distant metastatic head and neck cancer.
Maeda M; Yamashita T; Matsunobu T; Araki K; Tomifuji M; Shiotani A
Anticancer Res; 2013 Aug; 33(8):3285-9. PubMed ID: 23898093
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.
Wang T; Zhang SF; Qiu MQ; Li QL
Cancer Radiother; 2016 May; 20(3):181-6. PubMed ID: 27068497
[TBL] [Abstract][Full Text] [Related]
24. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
[TBL] [Abstract][Full Text] [Related]
25. [A case of lymph node metastasis after total laryngectomy successfully treated with chemoradiotherapy with TS-1].
Suzuki S; Yoshihara T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1945-7. PubMed ID: 14650964
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
Ohashi T; Ohnishi M; Tanahashi S; Murai M
Jpn J Clin Oncol; 2011 Mar; 41(3):348-52. PubMed ID: 21109512
[TBL] [Abstract][Full Text] [Related]
27. [A case report of tongue squamous cell carcinoma showing a complete response to TS-1].
Ikeda H; Takebe Y; Irie A; Mizoguchi Y; Yamada K; Shibahara K; Inokuchi T
Gan To Kagaku Ryoho; 2003 May; 30(5):677-9. PubMed ID: 12795100
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma of the extrahepatic bile duct with metachronous para-aortic lymph node metastasis successfully treated with S-1 plus cisplatin.
Nishiguchi R; Kim DH; Honda M; Sakamoto T
BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 27932438
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic radiosurgery in combination with chemotherapy as primary treatment for head and neck cancer.
Kawaguchi K; Sato K; Yamada H; Horie A; Nomura T; Iketani S; Kanai I; Suzuki S; Nakatani Y; Hamada Y
J Oral Maxillofac Surg; 2012 Feb; 70(2):461-72. PubMed ID: 21764492
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of microcystic adnexal carcinoma on the philtrum with oral S-1 monotherapy.
Haga T; Fujimura T; Aiba S
J Dermatol; 2019 Jun; 46(6):e208-e209. PubMed ID: 30663155
[No Abstract] [Full Text] [Related]
31. [A case of oral squamous cell carcinoma responding to S-1].
Harada K; Tamatani T; Bando T; Yoshida H
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1455-8. PubMed ID: 17876145
[TBL] [Abstract][Full Text] [Related]
32. [TS-1 and irradiation combination therapy for head and neck cancer].
Kawasaki M; Watanabe K; Watanabe J
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1077-80. PubMed ID: 16912525
[TBL] [Abstract][Full Text] [Related]
33. Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report.
Dirschka T; Schmitz L; Bartha Á
Eur J Dermatol; 2016 Aug; 26(4):408-9. PubMed ID: 27097553
[No Abstract] [Full Text] [Related]
34. The first case of phenytoin intoxication associated with the concomitant use of phenytoin and TS-1, a combination preparation of tegafur, gimeracil, and oteracil potassium.
Tsuda A; Fujiyama J; Miki A; Hori S; Ohtani H; Sawada Y
Cancer Chemother Pharmacol; 2008 Aug; 62(3):427-32. PubMed ID: 18026730
[TBL] [Abstract][Full Text] [Related]
35. Oral S-1 in advanced cutaneous squamous cell carcinoma.
Teramoto Y; Nakamura Y; Yamada K; Yamamoto A
J Dermatol; 2014 Jun; 41(6):494-7. PubMed ID: 24814954
[TBL] [Abstract][Full Text] [Related]
36. [Adjuvant chemotherapy with TS-1 for head and neck cancer--side effect of two-week application followed by one-week rest regimen].
Itoi A; Takashima M; Ishimasa H; Murata H; Tomoda K
Gan To Kagaku Ryoho; 2006 May; 33(5):617-20. PubMed ID: 16685159
[TBL] [Abstract][Full Text] [Related]
37. Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma.
Kim HR; Lee CG; Choi EC; Kim JH; Koh YW; Cho BC
Head Neck; 2016 Apr; 38 Suppl 1():E1653-9. PubMed ID: 26890965
[TBL] [Abstract][Full Text] [Related]
38. Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
Tahara M; Minami H; Kawashima M; Kawada K; Mukai H; Sakuraba M; Matsuura K; Ogino T; Hayashi R; Ohtsu A
Cancer Sci; 2011 Feb; 102(2):419-24. PubMed ID: 21134076
[TBL] [Abstract][Full Text] [Related]
39. Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
Fujii M; Tomita K; Nishijima W; Tsukuda M; Hasegawa Y; Ishitoya J; Yamane H; Homma A; Tomita T
Jpn J Clin Oncol; 2010 Mar; 40(3):214-21. PubMed ID: 19934112
[TBL] [Abstract][Full Text] [Related]
40. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]